NASDAQ:VXRT - Vaxart Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$3.16 +0.02 (+0.64 %)
(As of 07/16/2018 04:48 AM ET)
Previous Close$3.16
Today's Range$3.14 - $3.19
52-Week Range$2.76 - $11.88
Volume7,654 shs
Average Volume43,208 shs
Market Capitalization$22.57 million
P/E RatioN/A
Dividend YieldN/A
Beta0.12
Vaxart logoVaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.

Receive VXRT News and Ratings via Email

Sign-up to receive the latest news and ratings for VXRT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:VXRT
CUSIPN/A
Phone650-550-3500

Debt

Debt-to-Equity Ratio0.10
Current Ratio4.09
Quick Ratio4.09

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$8.90 million
Price / Sales2.54
Cash FlowN/A
Price / CashN/A
Book Value$5.32 per share
Price / Book0.59

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-29,400,000.00
Net Margins-286.74%
Return on Equity-202.17%
Return on Assets-37.17%

Miscellaneous

Employees16
Outstanding Shares7,140,000
Market Cap$22.57

The Truth About Cryptocurrencies

Vaxart (NASDAQ:VXRT) Frequently Asked Questions

What is Vaxart's stock symbol?

Vaxart trades on the NASDAQ under the ticker symbol "VXRT."

When did Vaxart's stock split? How did Vaxart's stock split work?

Vaxart's stock reverse split on Wednesday, February 14th 2018. The 1-11 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 13th 2018. An investor that had 100 shares of Vaxart stock prior to the reverse split would have 9 shares after the split.

How were Vaxart's earnings last quarter?

Vaxart Inc (NASDAQ:VXRT) issued its quarterly earnings data on Tuesday, May, 15th. The biotechnology company reported $0.49 earnings per share (EPS) for the quarter. The biotechnology company earned $1.50 million during the quarter. Vaxart had a negative net margin of 286.74% and a negative return on equity of 202.17%. View Vaxart's Earnings History.

What is the consensus analysts' recommendation for Vaxart?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vaxart in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."

Who are some of Vaxart's key competitors?

Who are Vaxart's key executives?

Vaxart's management team includes the folowing people:
  • Dr. Wouter W. Latour M.B.A., M.D., MBA, Pres, CEO & Director (Age 60)
  • Dr. Sean N. Tucker, Founder & Chief Scientific Officer (Age 50)
  • Mr. John M. Harland M.B.A., CPA, CFO & Sec. (Age 66)
  • Mr. Brant Biehn, Sr. VP of Commercial Operations
  • Dr. David N. Taylor, Chief Medical Officer (Age 69)

Has Vaxart been receiving favorable news coverage?

Headlines about VXRT stock have trended somewhat positive this week, Accern Sentiment reports. The research group scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Vaxart earned a media sentiment score of 0.08 on Accern's scale. They also assigned press coverage about the biotechnology company an impact score of 45.21 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

How do I buy shares of Vaxart?

Shares of VXRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vaxart's stock price today?

One share of VXRT stock can currently be purchased for approximately $3.16.

How big of a company is Vaxart?

Vaxart has a market capitalization of $22.57 million and generates $8.90 million in revenue each year. Vaxart employs 16 workers across the globe.

How can I contact Vaxart?

Vaxart's mailing address is 290 Utah Ave. Suite 200, South San Francisco CA, 94080. The biotechnology company can be reached via phone at 650-550-3500 or via email at [email protected]


MarketBeat Community Rating for Vaxart (NASDAQ VXRT)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  119 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  212
MarketBeat's community ratings are surveys of what our community members think about Vaxart and other stocks. Vote "Outperform" if you believe VXRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VXRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.